Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
What is the purpose of this trial?
Single arm, open-label study to provide Defibrotide to patients diagnosed with VOD. Defibrotide is no longer available though the Emergency Use IND mechanism (also known as compassionate use, or single patient named use). This protocol is the only mechanism by which Defibrotide can be made available to patients in the U.S.
- N/A - N/A
- Jazz Pharmaceuticals
- December 2007
- Last Updated:
- April 7, 2015
- Study HIC#:
Clinicaltrials.gov ID: NCT00628498